And one release of our typically half cocked paper work would probably reveal why.
That and what health Minister wants to get involved in meddling with approving health products? It's not like our product is life and death.
Clearly we have neglected the Aus market for years (and the good news stories and goodwill that would have gone with it) - so why start now when the story looks more like a Greek tragedy than a bright bio future for Australian start ups. More likely an Asian success story now.
Ann: Admedus Secures Strategic Investor, page-280
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.10 |
Change
-0.050(0.33%) |
Mkt cap ! $292.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $47.27K | 3.109K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 343 | $15.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.19 | 62 | 2 |
View Market Depth
| Last trade - 12.11pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |